Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity-Reference-Cited by-同舟云学术

Type II Chemotherapy-Related Cardiac Dysfunction: Time to Recognize a New Entity

Published:2005-05-01 Issue:13 Volume:23 Page:2900-2902
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Ewer Michael S.¹,Lippman Scott M.¹

Affiliation:

1. Departments of Cardiology and Clinical Cancer Prevention and Thoracic/Head and Neck Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2005.05.827

Reference22 articles.

1. Cardiovascular Complications of Cancer Therapy

2. A clinicopathologic analysis of adriamycin cardiotoxicity

3. Risk Factors for Doxorubicin-lnduced Congestive Heart Failure

4. Billingham M, Mason J, Bristow M, et al: Anthracycline cardiomyopathy monitored by morphologic changes. Cancer Treat Rep 62:865,1978-872,

5. Assessment of Anthracycline Cardiomyopathy by Endomyocardial Biopsy

Cited by 530 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “The protective effect of nano curcumin supplementation on doxorubicin induced cardiotoxicity in breast cancer patients; a randomized, double-blind clinical trial”;Journal of Oncology Pharmacy Practice;2024-09-02

2. Noncoding RNA-associated competing endogenous RNA networks in trastuzumab-induced cardiotoxicity;Non-coding RNA Research;2024-09

3. Increasing survivors of anthracycline-related cardiomyopathy with breast cancer in trastuzumab era: thirty-one-year trends in a Japanese Community;Breast Cancer;2024-08-13

4. The significance of the apelinergic system in doxorubicin-induced cardiotoxicity;Heart Failure Reviews;2024-07-11

5. Assessment of cardiotoxicity in cancer patients on chemotherapy in a low resource setting: is echocardiography the ultimate tool, or should we look for another?;Annals of Clinical and Biomedical Research;2024-06-28